Shuanghuanglian Injection Market

Shuanghuanglian preparation is composed of honeysuckle, scutellaria root, and forsythia. Chinese medicine believes that these three flavors of Chinese medicine have a good effect of clearing away heat and detoxifying, and clearing both inside and outside. Modern medical research believes that Shuanghuanglian oral liquid has the functions of broad-spectrum antiviral, bacteriostatic and improves the body's immune function, and is one of the currently effective broad-spectrum antiviral drugs.

Shuanghuanglian Injection Market contains market size and forecasts of Shuanghuanglian (SHL) Injection in global, including the following market information:

Global Shuanghuanglian (SHL) Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Shuanghuanglian (SHL) Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Shuanghuanglian (SHL) Injection companies in 2021 (%)

The global Shuanghuanglian (SHL) Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

20ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Shuanghuanglian (SHL) Injection include Harbin Pharmaceutical Group, Fusen Pharmaceutical and Gerun Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Shuanghuanglian (SHL) Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Shuanghuanglian (SHL) Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Shuanghuanglian (SHL) Injection Market Segment Percentages, by Type, 2021 (%)

20ml

Other

Global Shuanghuanglian (SHL) Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Shuanghuanglian (SHL) Injection Market Segment Percentages, by Application, 2021 (%)

Adult

Children

Global Shuanghuanglian (SHL) Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Shuanghuanglian (SHL) Injection Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Shuanghuanglian (SHL) Injection revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Shuanghuanglian (SHL) Injection revenues share in global market, 2021 (%)

Key companies Shuanghuanglian (SHL) Injection sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Shuanghuanglian (SHL) Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Harbin Pharmaceutical Group

Fusen Pharmaceutical

Gerun Pharmaceutical